Latest Myelin Stories
2010: A Year of Significant Progress in MS Research (Vocus/PRWEB) December 20, 2010 Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS.
National MS Society Leads the Way in Cutting Edge Research to Stop MS, Restore Function and End MS Forever NEW YORK, Dec. 20, 2010 /PRNewswire-USNewswire/ -- Exciting advances were made in 2010 in virtually every field of MS research.
Mile7 recognized for creativity and excellence on the web with Silver Award for the website, WhereAreTheCures.org Portland, OR (PRWEB) November 25, 2010 Mile7, a web application development company working from Portland, Oregon, today announced that it had won a Silver Award for design and development of wherearethecures.org, created for the Myelin Repair Foundation.
You may not be able to teach an old dog new tricks, but you can repurpose medicine with those intentions.
Researchers have found evidence that an environmental pollutant may play an important role in causing multiple sclerosis and that a hypertension drug might be used to treat the disease.
Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain.
By tracking the fate of a group of immature cells that persist in the adult brain and spinal cord, Johns Hopkins researchers discovered in mice that these cells undergo dramatic changes in ALS, also known as Lou Gehrig's disease.
NEW YORK and NORTH BRUNSWICK, N.J., Nov.
The complexity of the immune system and nervous system turn Neuroimmunology into one of the most exciting fields of modern biomedicine.
Scientists are closer to solving one of the many mysteries of multiple sclerosis and other demyelinating diseases, thanks to a recent study conducted at the Salk Institute for Biological Studies.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.